Rheumagen

Developer of therapeutics for auto-immune diseases

placeDenver, Colorado, United States calendar_todayFounded 2019 groups4 employees language rheumagen.com

Social engagement

Social engagement: 1.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include SPRIM Global Investments.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

22 Jun 2026
Event
BIO International Convention
17 Mar 2026
Partnership
CU Anschutz | Innovations, ClinImmune Cell & Gene Therapy, Fitzsimons Innovation Community
23 Dec 2025
Event
JPM2026 planning
Coming soon